Heron Therapeutics Inc vs PubMatic Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: PubMatic Inc is far larger — about 13.1× Heron Therapeutics Inc's market cap, and PubMatic Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | PUBM | |
|---|---|---|
Market Cap | $61.47M | $804.41M |
Sector | Health | Technology |
52-Week High | $1.49 | $17.78 |
52-Week Low | $0.32 | $6.28 |
Enterprise Value | $168.21M | $707.54M |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →